Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Neoadjuvant Chemotherapy Versus Immediate Nephroureterectomy in the Treatment of Localized Upper Tract Urothelial Carcinoma: A Randomized Controlled Trial

NCT07492225 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07492225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Neoadjuvant Chemotherapy Versus Immediate Nephroureterectomy in the Treatment of Localized Upper Tract Urothelial Carcinoma: A Randomized Controlled Trial
Lead sponsor
Changhai Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 15, 2025
Completion date
August 15, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoadjuvant therapy, upper urinary tract urothelial carcinoma, urothelial carcinoma ureter